Search Results - "Reingold, S C"

Differential diagnosis of suspected multiple sclerosis: a consensus approach by Miller, DH, Weinshenker, BG, Filippi, M, Banwell, BL, Cohen, JA, Freedman, MS, Galetta, SL, Hutchinson, M, Johnson, RT, Kappos, L, Kira, J, Lublin, FD, McFarland, HF, Montalban, X, Panitch, H, Richert, JR, Reingold, SC, Polman, CH

“…Background and objectives Diagnosis of multiple sclerosis (MS) requires exclusion of diseases that could better explain the clinical and paraclinical findings…”
Get full text

The Multiple Sclerosis Functional Composite measure (MSFC): an integrated approach to MS clinical outcome assessment by Fischer, J S, Rudick, R A, Cutter, G R, Reingold, S C

“…Clinical outcome assessment in Multiple Sclerosis (MS) is challenging due to the diversity and fluctuating nature of MS symptoms. Traditional clinical scales…”
Get full text

The role of magnetic resonance techniques in understanding and managing multiple sclerosis by MILLER, D. H, GROSSMAN, R. I, REINGOLD, S. C, MCFARLAND, H. F

“…Magnetic resonance (MR) techniques have had a major impact in the last 10-15 years in understanding and managing multiple sclerosis. This review summarizes the…”
Get full text

Magnetic resonance imaging as a surrogate outcome for multiple sclerosis relapses by Petkau, J, Reingold, SC, Held, U, Cutter, GR, Fleming, TR, Hughes, MD, Miller, DH, McFarland, HF, Wolinsky, JS

“…Background Magnetic resonance imaging (MRI) of lesions in the brain may be the best current candidate for a surrogate biological marker of clinical outcomes in…”
Get full text

Defining the clinical course of multiple sclerosis : Results of an international survey by LUBLIN, F. D, REINGOLD, S. C

Get full text

The challenge of follow-on biologics for treatment of multiple sclerosis by REINGOLD, S. C, STEINER, J. P, POLMAN, C. H, COHEN, J. A, FREEDMAN, M. S, KAPPOS, L, THOMPSON, A. J, WOLINSKY, J. S

“…Intellectual property protections for biologic medicinals for multiple sclerosis (MS) are beginning to expire, opening the possibility of development,…”
Get full text

Vision and vision-related outcome measures in multiple sclerosis by Balcer, Laura J, Miller, David H, Reingold, Stephen C, Cohen, Jeffrey A

“…Visual impairment is a key manifestation of multiple sclerosis. Acute optic neuritis is a common, often presenting manifestation, but visual deficits and…”
Get full text

Revised estimate of the prevalence of multiple sclerosis in the United States by Anderson, D W, Ellenberg, J H, Leventhal, C M, Reingold, S C, Rodriguez, M, Silberberg, D H

“…Using three adjustments, we have revised a 1976 prevalence count for multiple sclerosis in the United States. The adjustments were made to data from a US…”
Get more information

The future of multiple sclerosis therapies: redesigning multiple sclerosis clinical trials in a new therapeutic era by McFarland, H F, Reingold, S C

“…Due to past success in testing and gaining regulatory approval for a variety of therapies in multiple sclerosis (MS), the conduct of future clinical trials has…”
Get full text

Proof of concept studies for tissue-protective agents in multiple sclerosis by Mehta, LR, Schwid, SR, Arnold, DL, Cutter, GR, Aradhye, S, Balcer, LJ, Calabresi, PA, Cohen, JA, Cole, PE, Glanzman, R, Goelz, S, Inglese, M, Kapoor, R, Kappos, L, Kreitman, R, Lublin, FD, Mann, A, Marrie, RA, O'Looney, P, Polman, CH, Ravina, BM, Reingold, SC, Richert, JR, Sandrock, AW, Waubant, E

“…Background There is considerable interest in tissue-protective treatments for multiple sclerosis (MS). Methods and Objectives We convened a group of MS…”
Get full text

High Efficiency Total Absorption Spectrometer HECTOR for capture reaction measurements by Reingold, C. S., Olivas-Gomez, O., Simon, A., Arroyo, J., Chamberlain, M., Wurzer, J., Spyrou, A., Naqvi, F., Dombos, A. C., Palmisano, A., Anderson, T., Clark, A. M., Frentz, B., Hall, M. R., Henderson, S. L., Moylan, S., Robertson, D., Skulski, M., Stech, E., Strauss, S. Y., Tan, W. P., Vande Kolk, B.

“… Proper understanding of the stellar nucleosynthesis processes requires information on a variety of capture reaction cross sections. Since these cross…”
Get full text

Stem cell therapy in multiple sclerosis: promise and controversy by Duncan, ID, Goldman, S, Macklin, WB, Rao, M, Weiner, LP, Reingold, SC

“…Stem cells offer the potential for regeneration of lost tissue in neurological disease, including multiple sclerosis (MS). Their development in vitro and their…”
Get full text

Outcomes assessment in multiple sclerosis clinical trials: a critical analysis by Whitaker, J N, McFarland, H F, Rudge, P, Reingold, S C

“…The feasibility and precision of clinical trials for the treatment of MS must be improved. Subsequent to the approval by the Food and Drug Administration of…”
Get more information

Recommended diagnostic criteria for multiple sclerosis: Guidelines from the international panel on the diagnosis of multiple sclerosis by McDonald, W. Ian, Compston, Alistair, Edan, Gilles, Goodkin, Donald, Hartung, Hans-Peter, Lublin, Fred D., McFarland, Henry F., Paty, Donald W., Polman, Chris H., Reingold, Stephen C., Sandberg-Wollheim, Magnhild, Sibley, William, Thompson, Alan, Van Den Noort, Stanley, Weinshenker, Brian Y., Wolinsky, Jerry S.

“…The International Panel on MS Diagnosis presents revised diagnostic criteria for multiple sclerosis (MS). The focus remains on the objective demonstration of…”
Get full text

Ethics of placebo-controlled clinical trials in multiple sclerosis: a reassessment by Polman, C H, Reingold, S C, Barkhof, F, Calabresi, P A, Clanet, M, Cohen, J A, Cutter, G R, Freedman, M S, Kappos, L, Lublin, F D, McFarland, H F, Metz, L M, Miller, A E, Montalban, X, O'Connor, P W, Panitch, H, Richert, J R, Petkau, J, Schwid, S R, Sormani, M P, Thompson, A J, Weinshenker, B G, Wolinsky, J S

“…The increasing number of established effective therapies for relapsing multiple sclerosis (MS) and emerging consensus for early treatment raise practical…”
Get full text

Combination therapy for treatment of multiple sclerosis by Lublin, F D, Reingold, S C

Get more information

The future of multiple sclerosis therapies: redesigning multiple sclerosis clinical trials in a new therapeutic eraa by McFarland, H F, Reingold, S C

“…Due to past success in testing and gaining regulatory approval for a variety of therapies in multiple sclerosis (MS), the conduct of future clinical trials has…”
Get full text

Nuclear level densities and gamma-ray strength functions in samarium isotopes by Naqvi, F, Simon, A, Guttormsen, M, Schwengner, R, Frauendorf, S, Reingold, C. S, Burke, J. T, Cooper, N, Hughes, R. O, Ota, S, Saastamoinen, A

“…The gamma-strength functions and level densities in the quasi-continuum of 147;149Sm isotopes have been extracted from particle-coincidences using the Oslo…”
Get full text

Human T-lymphotrophic virus type I and multiple sclerosis by Antel, J, Bangham, C, Reingold, S C

Get more information

Performance of the Versatile Array of Neutron Detectors at Low Energy (VANDLE) by Peters, W.A., Ilyushkin, S., Madurga, M., Matei, C., Paulauskas, S.V., Grzywacz, R.K., Bardayan, D.W., Brune, C.R., Allen, J., Allen, J.M., Bergstrom, Z., Blackmon, J., Brewer, N.T., Cizewski, J.A., Copp, P., Howard, M.E., Ikeyama, R., Kozub, R.L., Manning, B., Massey, T.N., Matos, M., Merino, E., O'Malley, P.D., Raiola, F., Reingold, C.S., Sarazin, F., Spassova, I., Taylor, S., Walter, D.

“…The Versatile Array of Neutron Detectors at Low Energy (VANDLE) is a new, highly efficient plastic-scintillator array constructed for decay and transfer…”
Get full text